Target intelligence / Profile preview

Immunoglobulin heavy variable 3-30 (IGHV3-30)

Target
IGHV3-30
Molecular classification
Immunoglobulin variable region, Antibody variable domain, Immunoglobulin gene segment
01

Overview

Immunoglobulin heavy variable 3-30 is a gene segment encoding the variable region of immunoglobulin heavy chains, which forms part of the antigen-binding site of antibodies. This variable region, together with the light chain variable region, determines the specificity and affinity of the antibody for antigens, playing a central role in the humoral immune response. These segments undergo somatic recombination (V-D-J rearrangement) during B cell development, contributing to the diversity of antibody repertoires needed for immune defense. IGHV3-30 is not itself a receptor, enzyme, or typical drug target but is instead a source of antibody gene diversity, essential for recognizing a wide variety of pathogens[1][4].

Other names
IGHV3-30Ig heavy chain V-III region BURIg heavy chain V-III region CAMIg heavy chain V-III region GAIg heavy chain V-III region NIEIGHV330VHimmunoglobulin heavy chain variable region
02

Biological functions

Antigen bindingHumoral immune response
03

Disease associations

Contributes to immune response diversity and may be relevant in infection or autoimmune disease as part of antibody diversity, but is not itself a direct disease driver

Beyond the preview

Go deeper on Immunoglobulin heavy variable 3-30 (IGHV3-30).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 3-30 (IGHV3-30).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call